The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Acute Coronary Syndrome, Angiographic Evidence if Coronary Aneurysms, Ectasia. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
ITAlian Coronary Artery Aneurysm and Ectasia Observational Study in Patients With Acute Coronary Syndrome: The ITACA Registry
Overview
The ITACA study is a prospective, observational no profit registry enrolling patients with Acute Coronary Syndrome and angiographic evidence of coronary aneurysms and/or ectasia.
Detailed description
The ITACA study is aimed at evaluating short and long term outcomes in patients with acute coronary sindrome and angiographic evidence of coronary aneurysm and/or actasia. Data regarding safety and effectiveness of invasive and pharmacological treatment strategies will be also collected.
Primary outcome measures
- Major adverse cardiac events [Time frame: two years]
Eligibility criteria
Inclusion criteria
- Signature of informed consent;
- Patients aged ≥18 years;
- diagnosis of ACS (ST-elevation myocardial infarction, non ST-elevation myocardial infarction, unstable angina), in accordance with the definition provided in the latest guidelines;
- diagnosis of ectasia or coronary aneurysm according to the definitions contained in this protocol, either in the culprit vessel of the SCA than in another vessel. Coronary pseudoaneurysms are excluded.
Exclusion criteria
- impossibility or unwillingness to provide signed informed consent;
- contraindications to dual antiplatelet therapy;
- contraindications to anticoagulant therapy;
- active bleeding or severe anemia (Hb <6 g / dl);
- life expectancy <12 months;
- female patients with potential pregnancy;
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Italy · 2 centers
- Giuseppe Tarantino — Forlì
- Professor Giovanni Esposito — Naples
Identifiers
NCT: NCT05051917 · 22/21